Stockreport

Xeris Biopharma: A Balanced Perspective Needed (Rating Downgrade) [Seeking Alpha]

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report
PDF Gross margin improved to 85%, yet investors reacted to slowing Recorlev growth and rising costs from Recorlev expansion and XP-8121 clinical trials. I downgrade XERS [Read more]